Since PCAT29 is negatively regulated by IL-6 and positively regulated by resveratrol, we decided to investigate the functional role of PCAT29. First siRNA was designed to knockdown the expression of PCAT29 in prostate cancer cells. This evidence concerns the gene IL6 and prostate carcinoma.